Bengaluru, India

Indasi Gopi Kumar

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Indasi Gopi Kumar. Retrieved from https://idiyas.com/inventor/indasi-gopi-kumar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 19.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Indasi Gopi Kumar: Innovator in Antiviral Compounds

Introduction

Indasi Gopi Kumar is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of antiviral research, particularly in the development of compounds that target the Hepatitis C virus.

Latest Patents

Indasi holds a patent for "Hepatitis C virus inhibitors." This patent is focused on antiviral compounds and specifically addresses combinations of compounds that can inhibit the function of the NS5A protein encoded by the Hepatitis C virus (HCV). The patent outlines compositions comprising such combinations and methods for inhibiting the function of the NS5A protein.

Career Highlights

Indasi Gopi Kumar is currently employed at Bristol-Myers Squibb Company, where he continues to work on innovative solutions in the field of antiviral therapies. His research has the potential to impact the treatment of Hepatitis C significantly.

Collaborations

Indasi has collaborated with notable colleagues, including Piyasena Hewawasam and John F Kadow, to advance his research and development efforts in antiviral compounds.

Conclusion

Indasi Gopi Kumar is a dedicated inventor whose work in antiviral research is paving the way for new treatments for Hepatitis C. His contributions are vital to the ongoing fight against viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…